Masonic Cancer Center announces the appointment of Dr. Carol Lange to Associate Director

Carol Lange, PhD, has been appointed to the leadership team of the Twin Cities’ only National Cancer Institute (NCI) designated comprehensive cancer center.

Dr. Lange has taken over the role of Associate Director (AD) for Basic Sciences at the Masonic Cancer Center. Lange, a Professor in the Departments of Medicine and Pharmacology at the University of Minnesota and the Tickle Family Land Grant Endowed Chair of Breast Cancer Research, previously served as the Co-Leader of the Cellular Mechanisms program at the cancer center before accepting this new role. 

“Dr. Lange was one of the first people I had the opportunity to recruit to the Masonic Cancer Center,” noted Douglas Yee, MD, Director of the Masonic Cancer Center. “Over the past two decades, she has established herself as a leader in the field of steroid hormone receptors and cancer. She has also taken a leadership role in training future scientists and in the Cellular Mechanisms Program. She is in an exceptional position to oversee the basic science research of MCC.”

In her role as the AD of Basic Sciences, Lange will help to support, strengthen, and guide the basic science portfolio of the Masonic Cancer Center, oversee internal grants programs that support our basic and translational scientists and their collaborators, and work to promote all aspects of our strategic mission that touch on basic and team-based science within the cancer research arena.

“I am excited to take on this important role and am honored to represent the basic science mission of the MCC. I am especially interested in leveraging our members for strong collaborative and team-based science,” said Dr. Lange. “I look forward to promoting a rich and diverse basic science environment for everyone, and in particular, to working with Dr. Largaepada to build a community that supports our talented postdocs and junior faculty members.”

As Lange takes over this role, Kaylee Schwertfeger, PhD, Professor in the Medical School’s Department of Laboratory Medicine and Pathology, has been appointed to take over Lange’s former role as the Co-Leader of the Cellular Mechanisms program.

Lange’s appointment became effective on October 11, 2021.

Please join us in congratulating Dr. Lange on her new position.

About the Masonic Cancer Center

The Masonic Cancer Center, University of Minnesota, is the Twin Cities’ only Comprehensive Cancer Center, designated ‘Outstanding’ by the National Cancer Institute. As Minnesota’s Cancer Center, we have served the entire state for more than 25 years. Our researchers, educators, and care providers have worked to discover the causes, prevention, detection, and treatment of cancer and cancer-related diseases. Learn more at